GlassScriptPhysician profile
Sean K Hirota
NPI 1942452271
$7,133.74
in general payments reported to CMS, 2019-2025
17 companies · $850 in 2025
The $850 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $116 · 2021: $306 · 2022: $1,077 · 2023: $578 · 2024: $3,435 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,210 · Food and Beverage: $1,076 · Travel and Lodging: $502 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,210.00 |
| Food and Beverage | $1,075.90 |
| Travel and Lodging | $501.96 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $3,422.70 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $592.66 | 2019-2024 | Lifevest |
| Philips North America LLC | $541.22 | 2025 | Coronary Undivided, Coronary Other |
| Astrazeneca Pharmaceuticals LP | $534.36 | 2019-2024 | Brilinta |
| Novartis Pharmaceuticals Corporation | $410.56 | 2019-2023 | |
| Abbott Laboratories | $388.03 | 2019-2025 | Mitraclip, Optis |
| Merck Sharp & Dohme LLC | $261.63 | 2022-2023 | Verquvo |
| Cardiovascular Systems INC. | $235.50 | 2019-2022 | |
| Abiomed | $157.61 | 2021-2025 | |
| Atricure, INC. | $142.38 | 2022 | |
| Shockwave Medical, INC | $110.08 | 2025 | |
| Medtronic, INC. | $82.42 | 2022-2024 | Onyx Frontier |
| Biotronik INC. | $76.09 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $60.18 | 2023-2025 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $59.18 | 2024-2025 | Camzyos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $31.35 | 2019-2020 | |
| Medtronic Vascular, INC. | $27.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Hirota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.